Professor, Internal Medicine, Virginia Tech Carilion School of Medicine
Cardiology
Dr. David C. Sane, MD
|
|
Give Review
David Sane practices Cardiology. He went to Duke University School of Medicine. Duke University School of Medicine is one of the top medical schools in the US. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care He received awards:"CMS Meaningful Use Stage 1 Certification". David C. Sane is a published doctor. He published 60 publications, including: 'Effects of Vessel Tortuosity on Coronary Hemodynamics: An Idealized and Patient-Specific Computational Study.' He accepts Medicare.
Publications
- Effects of Vessel Tortuosity on Coronary Hemodynamics: An Idealized and Patient-Specific Computational Study.
- ST-Elevation Myocardial Infarction and Myelodysplastic Syndrome with Acute Myeloid Leukemia Transformation.
- Percutaneous coronary intervention and the management of Acute coronary syndromes in patients with von Willebrand disease.
- Weekly Doxorubicin increases Coronary arteriolar wall and adventitial thickness.
- Cardiac manifestations of cutaneous Disorders.
- Calcification after Myocardial infarction is independent of amniotic fluid stem cell injection.
- Persistent erythema with niacin is not attributable to aspirin resistance.
- Cardiac rupture after Myocardial infarction: new insights from murine models.
- Chronic kidney Disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction.
- Link between ADAMTS-13 and troponin levels?
- Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and Coronary stenting.
- Telomerase-positive neutrophils: plaque "survivors" and restenosis.
- Letter by Sane regarding article, "New-onset Heart failure due to Heart muscle disease in childhood: a prospective study in the United kingdom and Ireland".
- Routine hematologic clinical tests as prognostic markers in patients with Acute coronary syndromes.
- ABO blood types: influence on infarct size, procedural characteristics and prognosis.
- Transglutaminases: the missing link in nephrogenic systemic fibrosis.
- CT findings in Acute myocarditis: 2 cases.
- Cocaine use is associated with an increased risk of stent thrombosis after percutaneous Coronary intervention.
- Beyond the platelet count: heparin antibodies as independent risk predictors.
- Effect of genetic variations in platelet glycoproteins Ibalpha and VI on the risk for coronary Heart disease events in postmenopausal women taking hormone therapy.
- Roles of transglutaminases in cardiac and vascular Diseases.
- PCI with and without abciximab after upstream eptifibatide use: outcomes in high-risk patients.
- Unfractionated heparin reduces the anti-platelet effects of abciximab but not eptifibatide during PCI.
- Angiotensin II type 1 receptor blockade prevents alcoholic Cardiomyopathy.
- Valsartan inhibits platelet activity at different doses in mild to moderate Hypertensives: Valsartan Inhibits Platelets (VIP) trial.
- Preprocedural white blood cell count and major adverse cardiac events late after percutaneous Coronary intervention in saphenous vein grafts.
- Statin therapy may be associated with lower mortality in patients with diastolic Heart failure: a preliminary report.
- Differences in baseline characteristics and in-hospital outcomes in patients with or without prior stroke undergoing percutaneous Coronary intervention.
- Engineering of a recombinant vitamin K-dependent gamma-carboxylation system with enhanced gamma-carboxyglutamic acid forming capacity: evidence for a functional CXXC r...
- IRAK1 serves as a novel regulator essential for lipopolysaccharide-induced interleukin-10 gene expression.
- Superior in-hospital and 30-day outcomes with abciximab versus eptifibatide: a contemporary analysis of 495 consecutive percutaneous Coronary interventions.
- Stroke prevention: optimizing the response to a common threat.
- Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study.
- Regulator of G protein signaling 5 marks peripheral arterial smooth muscle cells and is downregulated in atherosclerotic plaque.
- The inhibitory effect of calumenin on the vitamin K-dependent gamma-carboxylation system. Characterization of the system in normal and warfarin-resistant rats.
- Case studies of HIT in cardiovascular medicine.
- Direct thrombin inhibitors in the treatment of immune-mediated heparin-induced thrombocytopenia.
- Role of anti-PF4/heparin antibodies in recurrent thrombotic events after Acute coronary syndromes.
- Effects of valsartan and valeryl 4-hydroxy valsartan on human platelets: a possible additional mechanism for clinical benefits.
- Relation of anemia to diastolic Heart failure and the effect on outcome.
- Risk of bleeding complications with antiplatelet agents: meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials.
- Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
- Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with Heart failure: the Plavix Us...
- Aging and coagulation.
- Intrabody and intrakine strategies for molecular therapy.
- Intrabody-based strategies for inhibition of vascular endothelial growth factor receptor-2: effects on apoptosis, cell growth, and angiogenesis.
- Anti-platelet factor 4/heparin antibodies: an independent predictor of 30-day myocardial infarction after Acute coronary ischemic syndromes.
- Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
- Angiostatin selectively inhibits signaling by hepatocyte growth factor in endothelial and smooth muscle cells.
- Abnormal angiogenesis in diabetes mellitus.
- Platelet activation in patients with congestive Heart failure: do we have enough evidence to consider clopidogrel?
- No effect of an L-arginine-enriched medical food (HeartBars) on endothelial function and platelet aggregation in subjects with hypercholesterolemia.
- Bicuspid Aortic valves in monozygotic twins.
- Aging and thrombosis.
- Vitamin K 2,3-epoxide reductase and the vitamin K-dependent gamma-carboxylation system.
- Frequency of aspirin resistance in patients with congestive Heart failure treated with antecedent aspirin.
- The Ultegra rapid platelet-function assay: comparison to standard platelet function assays in patients undergoing percutaneous Coronary intervention with abciximab the...
- Vascular origin of a soluble truncated form of the hepatocyte growth factor receptor (c-met).
- Reduced inhibition by abciximab in platelets with the PlA2 polymorphism.
Schools
Duke University
Duke University Med Center
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Duke University Hospital -
Duke University School of Medicine
Hospital
-
Carilion Roanoke Memorial Hospital
Drug Facts
| NPI NUMBER | 1780669077 | |
| NPPES Provider LastName | SANE | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 240141728 | |
| NPPES Provider State | VA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 24.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1780669077 |
| Last Name Of The Provider | SANE |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. John P. Bushkar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John C. Lystash, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carl W. Musser Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Starr III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Molly S. Rutherford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph L. Austin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary P. Swank, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Darron Lewis, MD |
|
|
Dr. Mohammed A. Farooqui, MD |
|
|
Rhonda L. Willoughby-Nunley, PA |
|
|
Kimberly D. Goad, NP
This Doctor is OpenDoctor Recommended.
|